AXSM
Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc. (AXSM) has 7 SEC Form 4 filings (15 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jul 1, 2026.
Insiders have net sold $13.5M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Herriot Tabuteau
- Employees:712
- HQ:New York City, NY, US
- IPO:2015-11-19
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$13.5M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$12.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
TABUTEAU HERRIOTFirst filing | Chief Executive Officer | Sale | 49,666 | $11.9M | Jul 1 | SEC ↗ |
| Director | Sale | 286 | $70K | Jun 12 | SEC ↗ | |
| Director | Sale | 286 | $71K | Jun 12 | SEC ↗ | |
Mahony SusanFirst filing | Director | Sale | 300 | $71K | Jun 11 | SEC ↗ |
Mahony SusanFirst filing | Director | Sale | 300 | $74K | Jun 11 | SEC ↗ |
Coleman MarkFirst filing | Director | Sale | 643 | $160K | Jun 11 | SEC ↗ |
Jacobson Mark L.First filing | Chief Operating Officer | Sale | 4,517 | $1.0M | May 6 | SEC ↗ |
Jacobson Mark L.First filing | Chief Operating Officer | Sale | 233 | $53K | May 6 | SEC ↗ |
Related companies
Axsome Therapeutics, Inc. is in the Healthcare sector.